Denali Capital Acquisition Corp.
announcedU=S+W/2W=S@11.50
SMNR
Capital Structure & Economics
Trust Size$75,000,000
Unit Price$10.00
Warrant Coverage1/2
Sponsor Promote20%
Implied Equity Architecture
Capital Allocation Baseline
Trust (100.0%)
Implied Dilution Drag
50% Warrant Inclusion| Public Trust Allocation | $75,000,000 |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $10.00 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedMar 1, 2022
Target AnnouncedJan 25, 2023
Maturation Wall
N/A
Announced Target / M&A
- Target CompanySemnur Pharmaceuticals, Inc.
- SectorMedical Technology and Life Sciences
- Announced Deal Size$2,500,000,000
- Announcement Date2023-01-25
Board & Officers
- CEO
- Scilex Holding CompanyOfficer
- Officer
- You (“Patrick”) SunOfficer
- Director
- Director
- Director
- Director
- Director
- Director
- Director
Advanced Structuring Terms
| Target Sectors | Medical Technology and Life Sciences |
Syndicate & Advisors
- Denali UnderwritersLEAD
- LEAD
- LEAD
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.